Back to search

Article

Acoziborole resistance associated mutations in trypanosome CPSF3

2025-11-27

Abstract excerpt

Acoziborole is a safe, single dose, oral therapy, for treatment of both early and late-stage sleeping sickness, a deadly disease caused by African trypanosomes. Other benzoxaboroles show efficacy against other trypanosomatids, apicomplexans, fungi, bacteria, and viruses. Acoziborole targets the trypanosome pre-mRNA processing endonuclease, cleavage and polyadenylation specificity factor 3 (CPSF3), and triggers CPS...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
31b67504-021e-539f-b159-ed833084eff1
DOI
10.1101/2025.11.26.690711
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Acoziborole resistance associated mutations in trypanosome CPSF3DOI 10.1101/2025.11.26.690711
Select a neighboring publication to make it the new centre.